Chris von Heymann and Mike Sullivan

Chris von Heymann and Mike Sullivan

Plan sponsors will have a break from high-cost trends within their drug plans. The key is to use the time wisely to keep costs down in the future. The next one to two years may bring better days for Canadian drug plan sponsors. The cost drivers that have contributed to double-digit cost inflation within these […]

  • June 1, 2007 September 13, 2019
  • 00:00